Clinical Trials
21 trialsNCT07576335 2026-05-08
ROBOPREP
Surgical Outcomes Research Centre (SOuRCe)
Phase 2 Not yet recruiting
NCT05014776 2026-04-28
Study of CRS-207, Pembrolizumab, Ipilimumab, and Tadalafil in Metastatic Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT03785210 2026-02-23
Nivolumab (Anti-PD1), Tadalafil and Oral Vancomycin in People With Refractory Primary Hepatocellular Carcinoma or Liver Dominant Metastatic Cancer From Colorectal or Pancreatic Cancers
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT03993353 2026-02-12
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
University of California, San Diego
Phase 2 Completed
NCT07333976 2026-01-12
o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer
Tri-Service General Hospital
Phase 2 Completed
NCT05709574 2025-10-16
Tadalafil Effect + Chemotherapy in Resectable Gastric/GEJ Cancer
University of Arizona
Phase 2 Recruiting
NCT06717711 2024-12-05
RCT_LiESWT
Regina Elena Cancer Institute
Phase 3 Recruiting
NCT05558007 2024-10-22
Safety and Efficacy Evaluation of BZ371A Topically Applied on Prostatectomized Patients
Biozeus Biopharmaceutical S.A.
Phase 2 Recruiting
NCT04757662 2023-06-13
Tadalafil to Overcome Immunosuppression During Chemoradiotherapy for IDH-wildtype Grade III-IV Astrocytoma
Washington University School of Medicine
Phase 1 Completed
NCT02998736 2022-12-28
PERIOP-04
Ottawa Hospital Research Institute
Phase 1 Completed
NCT04069936 2022-08-02
Marrow Infiltrating Lymphocytes - Non-Small Cell Lung Cancer (MILsâ„¢ - NSCLC) Alone or in Combination With Nivolumab With or Without Tadalafil in Locally Advanced and Unresectable or Metastatic NSCLC
WindMIL Therapeutics
Phase 2 Terminated
NCT02544880 2021-06-15
PDE5 Inhibition Via Tadalafil to Enhance Anti-Tumor Mucin 1 (MUC1) Vaccine Efficacy in Patients With HNSCC
University of Miami
Phase 1 Completed
NCT01697800 2020-02-28
A Phase II Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT00894413 2019-06-11
A Trial of Tadalafil in Patients With Squamous Cell Carcinoma of the Upper Aero Digestive Tract
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Completed
NCT01374217 2018-12-10
Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT01342224 2018-04-12
Immunochemoradiotherapy in Patients With Pancreatic Cancer
Providence Health & Services
Phase 1 Completed
NCT00931528 2018-02-14
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
Radiation Therapy Oncology Group
Phase 3 Completed
NCT01903083 2018-02-01
CRIT
Providence Health & Services
Phase 1 Completed
NCT00843635 2015-10-19
Tadalafil in Treating Patients Undergoing Surgery for Cancer of the Oral Cavity or Oropharynx
University of Miami
Phase NA Completed
NCT00215631 2015-09-15
Can Tadalafil Maintain Erectile Function In Patients Treated With Radiotherapy For Prostate Cancer?
Erasmus Medical Center
Phase 3 Terminated
NCT00122499 2005-07-27
A Study to Assess the Efficacy of Tadalafil to Treat Erectile Dysfunction After Radiotherapy of Prostate Cancer
Erasmus Medical Center
Phase 3 Completed